anti-CD19 CAR T-cell therapy (B-cell malignancies), NCI, Kite Pharma
- Generic Name
- anti-CD19 CAR T-cell therapy (B-cell malignancies), NCI, Kite Pharma
Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath